期刊文献+

大剂量IVIG、PP联合小剂量IVIG对高致敏肾移植受者脱敏效果比较 被引量:1

Hyposensitization effect comparison of high-dose IVIG and low-dose IVIG united with plasmapheresis in high sensitization renal transplantation recipients
暂未订购
导出
摘要 目的观察并比较大剂量静注免疫球蛋白(IVIG)和血浆置换(PP)联合小剂量IVIG对高致敏肾移植受者脱敏的效果。方法高致敏肾移植受者28例,随机分为观察组15例和对照组13例。观察组采用PP联合小剂量IVIG静注,对照组采用大剂量IVIG静注脱敏。结果脱敏后对照组4例、观察组9例群体反应性抗体(PRA)下降,肾移植术l a后11、6例PRA反弹。两组PRA下降率和反弹率相比P均<0.05。对照组敏感者中4例、观察组6例发生急性排斥反应,两组急性排斥反应发生率相比P<0.05。结论与单用大剂量IVIG静注相比,PP联合小剂量IVIG静注能更有效降低高致敏肾移植受者PRA水平,降低术后急性排斥反应发生率。 Objective To observe the hyposensitization effect comparison of high-dose IVIG and low-dose IVIG united with plassmapheresis in high sensitization renal transplantation recipients. Methods 28 high sensitization renal transplantation recipients were divided into observe group( 15 cases) and control group( 13 cases). Low-dose IVIG and plasmapheresis were used in observe group and high-dose IVIG was used in control group. Results The PRA level of 9 cases in observe group and 4 cases in control group decreased. The PRA level of 6 cases in observe group and 11 cases in control group rebounced one year after renal transplanation. Acute rejection emerged in 4 cases in control group and 6 cases in observe group. Coneludion Conpared with high-dose IVIG, low-dose IVIG and plasmapheresis can decrease the PRA level and acute rejection rate effectively.
机构地区 郑州人民医院
出处 《山东医药》 CAS 北大核心 2010年第22期8-9,共2页 Shandong Medical Journal
关键词 肾移植 免疫球蛋白 血浆置换 急性排斥反应 renal transplantation immunoglobulin plasmapheresis acute rejection reaction
  • 相关文献

参考文献9

  • 1Racusen LC,Solez K,Colvin RB,et al.The Banff 97 working classification of renal allograft pathology[J].Kidney Int,1999,55(2):713-723.
  • 2郭娟,苗书斋,曲青山,陈国勇,孙建军.抗供者特异性抗体与肾移植后的急性排斥反应[J].中国组织工程研究与临床康复,2009,13(18):3417-3420. 被引量:2
  • 3Gloor J.Kidney transplantation in the hyperimmunized patient[J].Contrib Nephrol,2005,146(7):11-21.
  • 4Cardarelli F,Pascual M,Tolkoff-Rubin N,et al.Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation[J].Transplant Int,2005,18(5):532-540.
  • 5Eric MG,Linda RC,Brian F,et al.Detection of donor-specific antibodies using HLA-coated microspheres:another tool for kidney transplant risk stratification[J].Nephrol Dial Transplant,2006,21(9):2625-2629.
  • 6黄洪锋,陈江华,王逸民,吴建永,张建国,寿张飞,朱丽亚,袁静,朱琮.高敏受者肾移植术前双滤过法血浆分离治疗[J].中华泌尿外科杂志,2000,21(6):343-345. 被引量:14
  • 7袁小鹏,高伟,李杰,姜松,焦伟华,郭在柱,徐建华.高度致敏受者的肾移植术[J].中华器官移植杂志,2003,24(4):248-250. 被引量:14
  • 8Mao Q,Terasaki PI,Cai J,et al.Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study[J].Am J Transpl,2007,7(4):864-871.
  • 9Montgomery RA,Zachary AA,Racusen LC,et al.Plasmepheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be succeddfully transplanted into cross-match-positive recipients[J].Transplantion,2000,70(6):887-895.

二级参考文献20

  • 1孙启全.肾移植致敏受者处理措施的选择[J].肾脏病与透析肾移植杂志,2006,15(6):538-539. 被引量:8
  • 2Fuggle SV, Martin S. Tools for human leukocyte antigen antibody detection and their application to transplanting sensitized patients. Transplantation. 2008;86(3):384-390.
  • 3Muro M, Lorente S, Marin L, et al. Acute vascular rejection mediated by HLA antibodies in a cadaveric kidney recipient t:discrepancies between Flow PRATM, ELISA and CDC vs luminex screening. Nephrol Dial Transplant.2005;20:223-226.
  • 4Roberti I, Vyas S, Pancoska C, et al. Donor-specific antibodies by flow single antigen beads in pediatric living donor kidney transplants: single center experience. Pediatr Transplant. 2007;11 (8):901-905.
  • 5Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8(4):753-760.
  • 6Sohn YH, Cha CH, Kim MH, et al. Experience on Identification of Cross-Reactive Group Specificity Performed by Anti-human Globulin Panel Reactive Antibody Tests. Korean J Lab Med. 2008; 28(5):362-370.
  • 7Gibney EM, Cagle LR, Freed B, et al. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant. 2006;21 (9): 2625-2629.
  • 8Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Am J Transplant. 2008;8(2):324-331.
  • 9Rebellato LM, Ozawa M, Verbanac KM, et al. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development. Clin Transpl. 2006:241-253.
  • 10Pollinger HS, Stegall MD, Gloor JM, et al. Kidney transplantation in patients with antibodies against donor HLA class Ⅱ. Am J Transplant. 2007;7(4):857-863.

共引文献25

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部